Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endogun Medical Systems has received FDA clearance to market in the US its next-generation, single-incision, trans-vaginal EndoFast Reliant device for soft tissue reinforcement and attachment.
Subscribe to our email newsletter
Endogun’s product is aimed at offering a single-incision, simpler and safer procedure, which is performed entirely trans-vaginally.
Elad Naggar, chairman of the board, Endogun, said: “The FDA approval for our single use, disposable EndoFast Reliant product is a key milestone towards bringing Endogun’s products to the prolapse and stress urinary incontinence markets.”